Report Store mobile icon
Asia Pacific Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, End User, and Country: Trend Forecast and Growth Opportunity
Asia Pacific Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, End User, and Country: Trend Forecast and Growth Opportunity

2022

Asia Pacific Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, End User, and Country: Trend Forecast and Growth Opportunity

Asia Pacific Rapid Diagnostics will grow by 10.9% annually with a total addressable market cap of $ 129,373.7 million over 2022-2031

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

Highend Report

Highend report of this product is available

View

Asia Pacific Rapid Diagnostics will grow by 10.9% annually with a total addressable market cap of $ 129,373.7 million over 2022-2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, increase in awareness regarding early diagnosis of disease, and emerging technological innovations. Highlighted with 35 tables and 64 figures, this 126-page report “Asia Pacific Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific Rapid Diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific Rapid Diagnostics market in every aspect of the classification from perspectives of Product, Prescription, Platform, Application, End User, and Country.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Consumables • Analyzers/Instruments Based on Prescription, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Professional Diagnostics • OTC Based Testing By Platform, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Immunoassays o Lateral Flow Assays o Serological Assays o Other Immunoassays • Molecular Detection o Polymerase Chain Reaction (PCR) o Other Molecular Detection Tests • Other Platforms

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Blood Glucose Testing • Cardiometabolic Testing • Infectious Disease Testing o COVID-19 Testing o Healthcare-associated Infections (HAI) Testing o Hepatitis Testing o Tropical Diseases Testing o HIV Testing o Influenza Testing o Sexually Transmitted Diseases (STD) Testing o Other Infectious Diseases Testing • Blood Coagulation Testing • Hematology Testing • Cancer Testing • Drug Abuse Testing • Pregnancy & Fertility Testing • Other Applications By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals & Clinics • Laboratories • Individuals/Homecare • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Prescription and Application over the forecast years are also included.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Diagnostics ACON Laboratories Becton Dickinson and Co. BioMérieux S.A. Bio-Rad Laboratories, Inc. Chembio Diagnostic Systems Danaher Corp. F. Hoffmann La Roche Ltd. GlySens Inc. Meridian Bioscience Inc. OraSure Technologies Inc. Siemens Healthineers AG Thermo Fisher Scientific Inc. Trinity Biotech Plc (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents

  • 1 Introduction 7
  • 1.1 Industry Definition and Research Scope 7
  • 1.1.1 Industry Definition 7
  • 1.1.2 Research Scope 8
  • 1.2 Research Methodology 11
  • 1.2.1 Overview of Market Research Methodology 11
  • 1.2.2 Market Assumption 12
  • 1.2.3 Secondary Data 12
  • 1.2.4 Primary Data 12
  • 1.2.5 Data Filtration and Model Design 13
  • 1.2.6 Market Size/Share Estimation 14
  • 1.2.7 Research Limitations 15
  • 1.3 Executive Summary 16
  • 2 Market Overview and Dynamics 19
  • 2.1 Market Size and Forecast 19
  • 2.1.1 Impact of COVID-19 on World Economy 20
  • 2.1.2 Impact of COVID-19 on the Market 24
  • 2.2 Major Growth Drivers 26
  • 2.3 Market Restraints and Challenges 32
  • 2.4 Emerging Opportunities and Market Trends 35
  • 2.5 Porter’s Fiver Forces Analysis 39
  • 3 Segmentation of Asia Pacific Market by Product 43
  • 3.1 Market Overview by Product 43
  • 3.2 Consumables 45
  • 3.3 Analyzers/Instruments 46
  • 4 Segmentation of Asia Pacific Market by Prescription 47
  • 4.1 Market Overview by Prescription 47
  • 4.2 Professional Diagnostics 49
  • 4.3 OTC Based Testing 50
  • 5 Segmentation of Asia Pacific Market by Platform 51
  • 5.1 Market Overview by Platform 51
  • 5.2 Immunoassays 53
  • 5.2.1 Lateral Flow Assays 55
  • 5.2.2 Serological Assays 56
  • 5.2.3 Other Immunoassays 57
  • 5.3 Molecular Detection 58
  • 5.3.1 Polymerase Chain Reaction (PCR) 59
  • 5.3.2 Other Molecular Detection Tests 60
  • 5.4 Other Platforms 61
  • 6 Segmentation of Asia Pacific Market by Application 62
  • 6.1 Market Overview by Application 62
  • 6.2 Blood Glucose Testing 64
  • 6.3 Cardiometabolic Testing 65
  • 6.4 Infectious Disease Testing 66
  • 6.4.1 COVID-19 Testing 68
  • 6.4.2 Healthcare-associated Infections (HAI) Testing 69
  • 6.4.3 Hepatitis Testing 70
  • 6.4.4 Tropical Diseases Testing 71
  • 6.4.5 HIV Testing 72
  • 6.4.6 Influenza Testing 73
  • 6.4.7 Sexually Transmitted Diseases (STD) Testing 74
  • 6.4.8 Other Infectious Diseases Testing 75
  • 6.5 Blood Coagulation Testing 76
  • 6.6 Hematology Testing 77
  • 6.7 Cancer Testing 78
  • 6.8 Drug Abuse Testing 79
  • 6.9 Pregnancy & Fertility Testing 80
  • 6.10 Other Applications 81
  • 7 Segmentation of Asia Pacific Market by End User 82
  • 7.1 Market Overview by End User 82
  • 7.2 Hospitals & Clinics 84
  • 7.3 Laboratories 85
  • 7.4 Individuals/Homecare 86
  • 7.5 Other End Users 87
  • 8 Asia-Pacific Market 2021-2031 by Country 88
  • 8.1 Overview of Asia-Pacific Market 88
  • 8.2 Japan 91
  • 8.3 China 94
  • 8.4 Australia 96
  • 8.5 India 98
  • 8.6 South Korea 100
  • 8.7 Rest of APAC Region 102
  • 9 Competitive Landscape 104
  • 9.1 Overview of Key Vendors 104
  • 9.2 New Product Launch, Partnership, Investment, and M&A 109
  • 9.3 Company Profiles 111
  • Abbott Diagnostics 111
  • ACON Laboratories 113
  • Becton Dickinson and Co. 114
  • BioMérieux S.A. 115
  • Bio-Rad Laboratories, Inc. 116
  • Chembio Diagnostic Systems 117
  • Danaher Corp. 118
  • F. Hoffmann La Roche Ltd. 119
  • GlySens Inc. 120
  • Meridian Bioscience Inc. 121
  • OraSure Technologies Inc. 122
  • Siemens Healthineers AG 123
  • Thermo Fisher Scientific Inc. 124
  • Trinity Biotech Plc 125
  • RELATED REPORTS 126

List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. Asia Pacific Rapid Diagnostics Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Rapid Diagnostics Market 26
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 29
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 30
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Rapid Diagnostics Market 32
Figure 11. Investment Opportunity Analysis 36
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific Rapid Diagnostics Market 39
Figure 13. Breakdown of Asia Pacific Rapid Diagnostics Market by Product, 2021-2031, % of Revenue 44
Figure 14. Asia Pacific Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 44
Figure 15. Asia Pacific Rapid Diagnostics Market by Product: Consumables, 2021-2031, $ mn 45
Figure 16. Asia Pacific Rapid Diagnostics Market by Product: Analyzers/Instruments, 2021-2031, $ mn 46
Figure 17. Breakdown of Asia Pacific Rapid Diagnostics Market by Prescription, 2021-2031, % of Sales Revenue 48
Figure 18. Asia Pacific Addressable Market Cap in 2022-2031 by Prescription, Value ($ mn) and Share (%) 48
Figure 19. Asia Pacific Rapid Diagnostics Market by Prescription: Professional Diagnostics, 2021-2031, $ mn 49
Figure 20. Asia Pacific Rapid Diagnostics Market by Prescription: OTC Based Testing, 2021-2031, $ mn 50
Figure 21. Breakdown of Asia Pacific Rapid Diagnostics Market by Platform, 2021-2031, % of Sales Revenue 52
Figure 22. Asia Pacific Addressable Market Cap in 2022-2031 by Platform, Value ($ mn) and Share (%) 52
Figure 23. Asia Pacific Rapid Diagnostics Market by Platform: Immunoassays, 2021-2031, $ mn 53
Figure 24. Asia Pacific Rapid Diagnostics Market by Immunoassays: Lateral Flow Assays, 2021-2031, $ mn 55
Figure 25. Asia Pacific Rapid Diagnostics Market by Immunoassays: Serological Assays, 2021-2031, $ mn 56
Figure 26. Asia Pacific Rapid Diagnostics Market by Immunoassays: Other Immunoassays, 2021-2031, $ mn 57
Figure 27. Asia Pacific Rapid Diagnostics Market by Platform: Molecular Detection, 2021-2031, $ mn 58
Figure 28. Asia Pacific Rapid Diagnostics Market by Molecular Detection: Polymerase Chain Reaction (PCR), 2021-2031, $ mn 59
Figure 29. Asia Pacific Rapid Diagnostics Market by Molecular Detection: Other Molecular Detection Tests, 2021-2031, $ mn 60
Figure 30. Asia Pacific Rapid Diagnostics Market by Platform: Other Platforms, 2021-2031, $ mn 61
Figure 31. Breakdown of Asia Pacific Rapid Diagnostics Market by Application, 2021-2031, % of Revenue 63
Figure 32. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 63
Figure 33. Asia Pacific Rapid Diagnostics Market by Application: Blood Glucose Testing, 2021-2031, $ mn 64
Figure 34. Asia Pacific Rapid Diagnostics Market by Application: Cardiometabolic Testing, 2021-2031, $ mn 65
Figure 35. Asia Pacific Rapid Diagnostics Market by Application: Infectious Disease Testing, 2021-2031, $ mn 66
Figure 36. Asia Pacific Rapid Diagnostics Market by Infectious Disease Testing: COVID-19 Testing, 2021-2031, $ mn 68
Figure 37. Asia Pacific Rapid Diagnostics Market by Infectious Disease Testing: Healthcare-associated Infections (HAI) Testing, 2021-2031, $ mn 69
Figure 38. Asia Pacific Rapid Diagnostics Market by Infectious Disease Testing: Hepatitis Testing, 2021-2031, $ mn 70
Figure 39. Asia Pacific Rapid Diagnostics Market by Infectious Disease Testing: Tropical Diseases Testing, 2021-2031, $ mn 71
Figure 40. Asia Pacific Rapid Diagnostics Market by Infectious Disease Testing: HIV Testing, 2021-2031, $ mn 72
Figure 41. Asia Pacific Rapid Diagnostics Market by Infectious Disease Testing: Influenza Testing, 2021-2031, $ mn 73
Figure 42. Asia Pacific Rapid Diagnostics Market by Infectious Disease Testing: Sexually Transmitted Diseases (STD) Testing, 2021-2031, $ mn 74
Figure 43. Asia Pacific Rapid Diagnostics Market by Infectious Disease Testing: Other Infectious Diseases Testing, 2021-2031, $ mn 75
Figure 44. Asia Pacific Rapid Diagnostics Market by Application: Blood Coagulation Testing, 2021-2031, $ mn 76
Figure 45. Asia Pacific Rapid Diagnostics Market by Application: Hematology Testing, 2021-2031, $ mn 77
Figure 46. Asia Pacific Rapid Diagnostics Market by Application: Cancer Testing, 2021-2031, $ mn 78
Figure 47. Asia Pacific Rapid Diagnostics Market by Application: Drug Abuse Testing, 2021-2031, $ mn 79
Figure 48. Asia Pacific Rapid Diagnostics Market by Application: Pregnancy & Fertility Testing, 2021-2031, $ mn 80
Figure 49. Asia Pacific Rapid Diagnostics Market by Application: Other Applications, 2021-2031, $ mn 81
Figure 50. Breakdown of Asia Pacific Rapid Diagnostics Market by End User, 2021-2031, % of Revenue 83
Figure 51. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 83
Figure 52. Asia Pacific Rapid Diagnostics Market by End User: Hospitals & Clinics, 2021-2031, $ mn 84
Figure 53. Asia Pacific Rapid Diagnostics Market by End User: Laboratories, 2021-2031, $ mn 85
Figure 54. Asia Pacific Rapid Diagnostics Market by End User: Individuals/Homecare, 2021-2031, $ mn 86
Figure 55. Asia Pacific Rapid Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 87
Figure 56. Breakdown of APAC Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue 89
Figure 57. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 90
Figure 58. Rapid Diagnostics Market in Japan, 2021-2031, $ mn 92
Figure 59. Rapid Diagnostics Market in China, 2021-2031, $ mn 94
Figure 60. Rapid Diagnostics Market in Australia, 2021-2031, $ mn 96
Figure 61. Rapid Diagnostics Market in India, 2021-2031, $ mn 98
Figure 62. Rapid Diagnostics Market in South Korea, 2021-2031, $ mn 100
Figure 63. Rapid Diagnostics Market in Rest of APAC, 2021-2031, $ mn 102
Figure 64. Growth Stage of Asia Pacific Rapid Diagnostics Industry over the Forecast Period 104

List of Tables:

Table 1. Snapshot of Asia Pacific Rapid Diagnostics Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 31
Table 5. Main Product Trends and Market Opportunities in Asia Pacific Rapid Diagnostics Market 35
Table 6. Asia Pacific Rapid Diagnostics Market by Product, 2021-2031, $ mn 43
Table 7. Asia Pacific Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 47
Table 8. Asia Pacific Rapid Diagnostics Market by Platform, 2021-2031, $ mn 51
Table 9. Asia Pacific Rapid Diagnostics Market: Immunoassays by Type, 2021-2031, $ mn 54
Table 10. Asia Pacific Rapid Diagnostics Market: Molecular Detection by Type, 2021-2031, $ mn 58
Table 11. Asia Pacific Rapid Diagnostics Market by Application, 2021-2031, $ mn 62
Table 12. Asia Pacific Rapid Diagnostics Market: Infectious Disease Testing by Type, 2021-2031, $ mn 67
Table 13. Asia Pacific Rapid Diagnostics Market by End User, 2021-2031, $ mn 82
Table 14. APAC Rapid Diagnostics Market by Country, 2021-2031, $ mn 89
Table 15. Japan Rapid Diagnostics Market by Product, 2021-2031, $ mn 93
Table 16. Japan Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 93
Table 17. Japan Rapid Diagnostics Market by Application, 2021-2031, $ mn 93
Table 18. China Rapid Diagnostics Market by Product, 2021-2031, $ mn 95
Table 19. China Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 95
Table 20. China Rapid Diagnostics Market by Application, 2021-2031, $ mn 95
Table 21. Australia Rapid Diagnostics Market by Product, 2021-2031, $ mn 97
Table 22. Australia Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 97
Table 23. Australia Rapid Diagnostics Market by Application, 2021-2031, $ mn 97
Table 24. India Rapid Diagnostics Market by Product, 2021-2031, $ mn 99
Table 25. India Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 99
Table 26. India Rapid Diagnostics Market by Application, 2021-2031, $ mn 99
Table 27. South Korea Rapid Diagnostics Market by Product, 2021-2031, $ mn 101
Table 28. South Korea Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 101
Table 29. South Korea Rapid Diagnostics Market by Application, 2021-2031, $ mn 101
Table 30. Rapid Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 103
Table 31. Rapid Diagnostic Analyzers by Vendor 106
Table 32. Recent Product Launches, 2018-2021 110
Table 33. Abbott Diagnostics: Company Snapshot 111
Table 34. Abbott Diagnostics: Business Segmentation 112
Table 35. Abbott Diagnostics: Product Portfolio 112

Related Tags

Related Reports

payment cards

Allows one individual to access the purchased report Read More

Allows all employees of an organization to access the purchased report. Internal sharing only Read More

Allows all employees of an organization to access the purchased report. It also permits the use of up to 4 paragraphs or 1 page of the report externally in whitepapers, press releases, and marketing collateral Read More

Buy Now

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Rishika Gupta

Rishika Gupta

Team Lead- Business Development

Trusted Partners

NONWOVENS_INDUSTRY
FB
issuewire
Financial_Express
logo_yourstory
FB

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

  • Order Placed (27 July, 2024)
  • Notify To Team (27 July, 2024)
  • Report updation (28 July, 2024)
  • Report Quality Check (28 July, 2024)
  • Report Dispatch (29 July, 2024)

  • paypal
  • icici
  • stripe
  • wire-transfer

  • Email
  • Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Recently Viewed Products

Logo

Asia Pacific Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, End User, and Country: Trend Forecast and Growth Opportunity

Contact usWe are friendly and approachable, give us a call.

We uses Cookies

We use cookies to ensure you get the best experience on our website.